|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/22 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61K 31/337 | (2006.01) | ||
| A61K 31/555 | (2013.01) | ||
| A61K 31/4709 | (2006.01) | ||
| A61K 31/4745 | (2006.01) | ||
| C07D 401/12 | (2013.01) | ||
| A61K 31/555 | (2006.01) | ||
| C07C 57/145 | (2013.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07C 55/10 | (2013.01) | ||
| C07K 16/22 | (2006.01) | ||
| A61K 31/4709 | (2013.01) | ||
| C07C 55/10 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| C07C 57/145 | (2006.01) | ||
| A61K 31/337 | (2013.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 33/243 | (2019.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61K 33/243 | (2019.01) |
| (11) | Number of the document | 3291814 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16789916.0 |
| Date of filing the European patent application | 2016-05-03 | |
| (97) | Date of publication of the European application | 2018-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/030483 |
| Date | 2016-05-03 |
| (87) | Number | WO 2016/179123 |
| Date | 2016-11-10 |
| (30) | Number | Date | Country code |
| 201562156734 P | 2015-05-04 | US | |
| 201562205272 P | 2015-08-14 | US | |
| 201615143630 | 2016-05-02 | US |
| (72) |
CHEN, Guoqing, Paul , US
YAN, Changren , US
|
| (73) |
Advenchen Pharmaceuticals, LLC ,
887 Patriot Drive, Ste A, Moorpark, CA 93021,
US
Chen, Guoqing Paul , 887 Patriot Drive, Ste A, Moorpark, CA 93021, US |
| (54) | AN ANTI-CANCER AGENT 1-((4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-6-METHOXYQUINOLIN-7-YLOXY)METHYL) CYCLOPROPANAMINE, ITS CRYSTALLINE FORM AND ITS SALTS |
| AN ANTI-CANCER AGENT 1-((4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-6-METHOXYQUINOLIN-7-YLOXY)METHYL) CYCLOPROPANAMINE, ITS CRYSTALLINE FORM AND ITS SALTS |